Guangzhou Baiyunshan Hanfang Launches ExportQualified Medicinal Injectable Soybean Oil

China-Based Pharma Firm Delivers Stable, Globally Compliant Injectable Excipient for High-End Formulation Manufacturers

Guangzhou, China – 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading global provider of high-end medicinal lipid excipients, today announced the launch of its export-qualified medicinal injectable soybean oil, available for shipment to over 20 countries worldwide. Designed to address the core pain point of unstable supply of imported injectable-grade excipients for pharmaceutical manufacturers, the product offers three key advantages: reliable domestic alternative, globally recognized certifications, and strict quality control. Orders are now open via the official website and authorized global distributors, with full-scale production and shipment starting in September 2026.

Core Product Value & Technical Highlights

As a specialized energy supplement and pharmaceutical excipient, the medicinal injectable soybean oil targets high-end injectable formulation manufacturers, providing a stable domestic supply alternative to imported products. Developed with integrated green production technologies, the product meets strict international injectable-grade standards, ensuring consistency and safety for clinical applications. It supports the production of a wide range of high-end injectables, including parenteral nutrition solutions and lipid-based drug delivery systems.

Global Compliance & Certifications

To meet global market access requirements, the product has obtained key international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. It complies with regulatory standards in the EU, North America, Asia-Pacific, and other major global markets, enabling seamless export and application across regions. The company’s compliance framework is backed by its status as a national specialized, sophisticated, unique, and new "Little Giant" enterprise and operator of the only national engineering research center for traditional Chinese medicine pharmaceutical technology.

Supply & Customization Services

In addition to standard product offerings, Guangzhou Hanfang Pharmaceutical Company Limited provides customized services for global enterprise clients, including tailored specifications and packaging to meet diverse formulation needs. Orders can be placed through the official website http://byshanhanfang.com/ or authorized distributors, with flexible delivery options to support global supply chain requirements.

Executive Quote

"The launch of our export-qualified medicinal injectable soybean oil marks a critical milestone in breaking international monopolies and securing global pharmaceutical supply chains," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited "We are dedicated to providing cost-effective, high-quality domestic alternatives to global partners, supporting their mission to deliver safe, accessible pharmaceutical products."

Industry Context & Strategic Alignment

According to Grand View Research, the global injectable excipients market is projected to reach $12.3 billion by 2026, driven by rising demand for biologic drugs and generic injectables. As a key player in the domestic medicinal lipid sector, Guangzhou Hanfang Pharmaceutical Company Limited’s new product addresses the growing global need for stable, reliable excipient supplies, aligning with its strategy to expand its global footprint.

Future Outlook

Looking ahead, the company will continue to invest in R&D for high-end medicinal lipid excipients, with plans to expand its global distribution network by adding 5 new authorized distributors in Europe and Southeast Asia by Q4 2026. It will also advance its green production technologies to further enhance product sustainability and compliance.

About Guangzhou Hanfang Pharmaceutical Company Limited

Founded in 1998, Guangzhou Hanfang Pharmaceutical Company Limited is a state-owned high-tech enterprise under Guangzhou Pharmaceutical Holdings, specializing in high-end medicinal lipid excipients, anti-tumor APIs, and Ganoderma health products. It operates the only national engineering research center for traditional Chinese medicine pharmaceutical technology, holds over 240 patents, and serves more than 1,000 clients across 20+ countries. Its mission is to achieve technological self-reliance, break "bottleneck" technologies, and safeguard pharmaceutical supply chain security.

Contact Information

Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Hanfang Pharmaceutical Company Limited All rights reserved.